What is the recommended daily dosage for fish oil supplements?

What is the recommended daily dosage for fish oil supplements?

We all know the heart-healthy staples: vegetables, low-fat dairy, and lean protein like fish. Fatty fish like salmon boast an extra benefit – omega-3 fatty acids, thought to improve good cholesterol and lower triglycerides. But recent research suggests a more nuanced picture for fish oil supplements and heart disease prevention. A new study in BMJ …

Read more

Fish Oil Supplements May Increase Risk Of Heart Diseases: Study

Fish Oil Supplements May Increase Risk Of Heart Diseases: Study

About 20% of adults over 60 in the US take these products. The study analysed data from more than 4,15,000 people, aged between 40 to 69. Fish is an excellent source of heart-healthy omega-3 fatty acids. Taking fish oil daily is a popular way to keep the risk of cardiovascular disease in check. About 20% …

Read more

Opportunistic atrial fibrillation screening key to preventing strokes

Opportunistic atrial fibrillation screening key to preventing strokes

People at risk should be tested for atrial fibrillation every time they attend a health appointment, according to results of the AFFECT-EU project, which is holding its final event today in Brussels, Belgium. Patients at high risk of the disorder, such as those with heart failure or prior stroke, should be invited for a screening …

Read more

Drinking sweetened drinks increases heart disease risk: Study

Drinking sweetened drinks increases heart disease risk: Study

Do you drink a lot of sweetened drinks regularly? Well, it can put you at risk of heart diseases like atrial fibrillation, says a study. It is better be careful of how much sugar goes into our bodies daily. One of the biggest culprits putting you at risk of developing diseases is sweetened drinks! Those …

Read more

Impressive Bleeding Profile With Factor XI Inhibitor in AF

Impressive Bleeding Profile With Factor XI Inhibitor in AF

xFurther details from the phase 2b AZALEA trial with the factor XI inhibitor abelacimab (Anthos) show significant reductions in major and clinically relevant nonmajor bleeding compared with rivaroxaban for patients with AF; the risk of stroke was moderate to high. The trial was stopped earlier this year because of an “overwhelming” reduction in bleeding with …

Read more

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

Major trial finds apixaban reduces stroke risk in patients with device-detected atrial fibrillation

The widely available blood thinner apixaban substantially reduced stroke in at-risk patients with a type of atrial fibrillation only detectable by a pacemaker or other implanted cardiac electronic device, a global study has found. The oral anticoagulant medication, which helps to prevent dangerous blood clots by thinning the blood, reduced the risk of stroke and …

Read more

Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF

Apixaban Cuts Stroke But Ups Bleeding in Subclinical AF

In patients with subclinical atrial fibrillation (AF) detected by implanted devices such as pacemakers or loop recorders, oral anticoagulation with apixaban resulted in a lower risk of stroke or systemic embolism than aspirin, but a higher risk of major bleeding in the ARTESIA study. The results appear to contrast somewhat with the recently reported NOAH-AFNET …

Read more